Market closedNon-fractional
Twist Bioscience/TWST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Twist Bioscience
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
Ticker
TWST
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
South San Francisco, United States
Employees
919
Website
www.twistbioscience.com
Twist Bioscience Metrics
BasicAdvanced
$3.3B
Market cap
-
P/E ratio
-$3.36
EPS
1.62
Beta
-
Dividend rate
Price and volume
Market cap
$3.3B
Beta
1.62
Financial strength
Current ratio
5.51
Quick ratio
4.896
Long term debt to equity
13.355
Total debt to equity
15.965
Interest coverage (TTM)
-97,320.00%
Management effectiveness
Return on assets (TTM)
-15.63%
Return on equity (TTM)
-30.40%
Valuation
Price to revenue (TTM)
11.896
Price to book
5.99
Price to tangible book (TTM)
7.95
Price to free cash flow (TTM)
-34.558
Growth
Revenue change (TTM)
21.79%
Earnings per share change (TTM)
-11.06%
3-year revenue growth (CAGR)
34.91%
3-year earnings per share growth (CAGR)
7.24%
What the Analysts think about Twist Bioscience
Analyst Ratings
Majority rating from 10 analysts.
Twist Bioscience Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$75M
5.46%
Net income
-$45M
5.58%
Profit margin
-60.29%
0.12%
Twist Bioscience Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
-$1.01
-$0.81
-$0.75
-$0.79
-
Expected
-$1.14
-$0.92
-$0.78
-$0.82
-$0.77
Surprise
-11.24%
-12.06%
-3.52%
-3.29%
-
Twist Bioscience News
AllArticlesVideos
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
Business Wire·2 months ago
Twist Bioscience to Present at Upcoming Investor Conferences
Business Wire·2 months ago
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Twist Bioscience stock?
Twist Bioscience (TWST) has a market cap of $3.3B as of July 27, 2024.
What is the P/E ratio for Twist Bioscience stock?
The price to earnings (P/E) ratio for Twist Bioscience (TWST) stock is 0 as of July 27, 2024.
Does Twist Bioscience stock pay dividends?
No, Twist Bioscience (TWST) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Twist Bioscience dividend payment date?
Twist Bioscience (TWST) stock does not pay dividends to its shareholders.
What is the beta indicator for Twist Bioscience?
Twist Bioscience (TWST) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Twist Bioscience stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.